Free Trial

Baxter Launched, Philip Morris Guidance Updated

PIPELINE
  • Date $MM Issuer (Priced *, Launch #)
  • 10/29 $650M #Baxter Int WNG 10Y +90
  • 10/29 $500M *Swedish Export Credit Corporation (SEK) 2Y +5
  • 10/29 $500M IFFIm 3Y Red S vaccine bond +18a
  • 10/29 $Benchmark Boeing 4pt: +3Y +195a, +5Y +255a, +7Y +280a, +10Y +300a (issued $25B via 7pt jumbo on April 30: $3B 3Y +425, +450: $3.5B 5Y, $2B 7Y, $4.5B 10Y and $5.5B 30Y, $3B 20Y +440, $3.5B 40Y +462.5)
  • 10/29 $Benchmark Philip Morris +5Y +60a, 10Y +105a (issued $2.25B on Apr 29: $750M each 3Y +100, 5Y +125 and 10Y +155)
  • 10/29 $Benchmark Stanley Black & Decker 30Y +130a
  • 10/29 $Benchmark State Development & Inv 5Y +160a

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.